Diabetes Drug for Cats Now Approved in Humans Too Oral SGLT2 inhibitor bexagliflozin indicated for adults with type 2 diabetes Jan 23, 2023
Sodium Nitrite in Food, Water Tied to Type 2 Diabetes Risk Observational study serves up "new piece of evidence" for debate over additives Jan 17, 2023
How Many Times Do You Need to Get Out of Your Chair in an Otherwise Sedentary Day? Trial tested walking break doses to counter ill effects of prolonged sitting Jan 12, 2023
Type 2 Diabetes Patients Can Also Benefit From Fully Closed-Loop System Users spent twice as much time in target glucose range vs standard insulin therapy, study showed Jan 11, 2023
Conspiracy Theorists' Cancer Beliefs; HIV Meds and Ethnicity Also in TTHealthWatch: sodium levels and health outcomes Jan 07, 2023 podcast
Fixing Heart Failure Workforce Issues: Baby Steps Start This Year Pay, curriculum changes proposed to attract more doctors Jan 05, 2023
Dementia Accompanying Cardiometabolic Disease: Does It Come Down to Genetics? Twin study suggests special monitoring in some individuals Dec 29, 2022
Competitor Poised to Take on Obesity Treatment Giant Wegovy in 2023 Both Eli Lilly and Novo Nordisk scramble to rectify supply shortages Dec 28, 2022
The Year SGLT2 Inhibitors Became Full-Fledged Heart Failure Drugs Treatment no longer limited by ejection fraction Dec 27, 2022
Glycemic Control With Insulin Barely Budged Over the Past 30 Years Rates of hyperglycemia also remained elevated for racial and ethnic minorities Dec 20, 2022
Metformin Protective Against Joint Replacement in Type 2 Diabetes Daily users saw lower risks for total knee, hip replacements Dec 19, 2022
Fecal Transplant Failed to Boost Effects of Bariatric Surgery No impact on weight loss or metabolism compared with placebo, small study found Dec 16, 2022
No Blaming Common Antihypertensives for Pancreatic Cancer, Study Suggests Some reassurance on widely prescribed dihydropyridine calcium channel blockers Dec 15, 2022
Innovation Is Critical to Stop Disparities in Diabetes Care We must explore how new technologies can help Dec 10, 2022
Do Kidney Transplant Medications Supplant IBD Drugs? Study shows many patients no longer need drugs to help keep gut disease in check Dec 08, 2022
TAVR at 20: How Much Longer Will Medicare Mandate a Registry? Change is a-comin' but interventionalists debate just how soon that should be and what comes next Dec 08, 2022
Should We Change Target Blood Pressure? Harlan Krumholz, MD, reviews cardiovascular studies and proposes ways to rethink patient outcomes Dec 07, 2022 video
Heart Failure From Meth Use: Growing Beast Lurks in the Shadows Exact scope of problem still unknown due to low clinician awareness Dec 02, 2022
Pre-Op Axitinib Helps for Partial Nephrectomy of Complex Renal Tumors Approach in small ongoing trial resulted in reduction in tumor size and complexity Dec 02, 2022
After Major Motorcycle Rallies, More Organs Available for Donation Study estimated 21% more organ donors, 26% more transplant recipients per day during rallies Nov 28, 2022
Combo Treatment Could Delay Kidney Failure for Years in Nondiabetic CKD Big benefits projected with SGLT2/RAAS inhibitor combination therapy Nov 23, 2022
Watch for Severe Hypocalcemia in Dialysis Patients on Prolia, FDA Warns Agency said potential risk may require more frequent blood calcium monitoring Nov 22, 2022
Treating Obesity Should Be Our Healthcare Moonshot Behavioral health changes alone will only do so much Nov 21, 2022
FDA Approves First Drug to Delay Onset of Type 1 Diabetes Teplizumab will not be subject to a risk evaluation and mitigation strategy program, after all Nov 18, 2022
FDA Panel Endorses Kidney Disease Drug for Serum Phosphorus Control Advisors see need for alternatives, citing suboptimal efficacy and tolerance of approved options Nov 17, 2022
Early Cardiac Amyloidosis Still Bad News Without Treatment Observational study supports treating even asymptomatic patients Nov 16, 2022
After Rejection, Tenapanor for Kidney Disease Faces FDA's Outside Experts Drug's effect on serum phosphorus "small and of unclear clinical significance," say FDA reviewers Nov 15, 2022
Low-Dose 'Quadpill' Reduces High Blood Pressure Significantly lower diastolic blood pressure at 12 weeks, U.S.-based study showed Nov 09, 2022
Strong Showing for Novel BP-Lowering Drugs in Resistant Hypertension Aprocitentan targets the endothelin pathway, whereas baxdrostat blocks aldosterone production Nov 09, 2022
Saline Goes Head-to-Head With Balanced Crystalloid IV Fluids for Kidney Transplant Researcher argued saline should be reconsidered as the standard IV fluid used Nov 07, 2022
Upfront ECMO Disappoints for Cardiogenic Shock High-cost procedure not yet justified as an early strategy Nov 07, 2022
Moving Fast on HF Drugs After Acute Hospitalization Holds Big Outcome Benefit Randomized trial shows advantages across heart failure spectrum Nov 07, 2022
Experts Agree Intravenous Iron Shows Promise for Heart Failure Patients While findings were not significant, the study was impacted by COVID lockdowns, researcher says Nov 07, 2022
Earlier Terlipressin May Be Better for HRS-AKI in Acute-on-Chronic Liver Failure More acute kidney injury reversals at 7 days and lower mortality with initiation at 12 hours Nov 07, 2022
Mixed Results With Alerts for AKI-Related Medications in Hospital EHR pings improved outcomes in those on PPIs, but lacked general clinical impact Nov 06, 2022
Decision-Support Tool Enhances Outcomes for Heart Failure Patients in the ED Pathways for HF patients picked for early discharge versus admission Nov 06, 2022
Diuretics on Par in Head-to-Head Comparison for Hypertension But a surprise signal emerges for one group in pragmatic trial Nov 06, 2022
Mixed Results With Pemafibrate in Patients With Type 2 Diabetes No impact on CV events in PROMINENT; developer brings trial to an end Nov 06, 2022
Not So Cool After All: No CV Benefit With Lower-Temp Dialysate in Hemodialysis Some patients in MyTEMP trial even complained cooler dialysate was "worst possible feeling" Nov 06, 2022
